Connection | Profiles RNS

Search Result Details

Back to Search Results

This page shows the details of why an item matched the keywords from your search.

Search Results

BAJAJ, MANDEEP

One or more keywords matched the following items that are connected to BAJAJ, MANDEEP

Item Type	Name
Academic Article	Blood glucose awareness training and epinephrine responses to hypoglycemia during intensive treatment in type 1 diabetes.
Academic Article	Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients.
Academic Article	Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients.
Academic Article	Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients.
Academic Article	Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes.
Academic Article	Type 2 diabetes treatment and macrovascular complications--fat and sugar make a dangerous souffl?.
Academic Article	Exenatide: a GLP-1 receptor agonist as novel therapy for Type 2 diabetes mellitus.
Academic Article	Phosphodiesterase-3 inhibition augments the myocardial infarct size-limiting effects of exenatide in mice with type 2 diabetes.
Academic Article	The effect of pioglitazone treatment on 15-epi-lipoxin A4 levels in patients with type 2 diabetes.
Academic Article	Effects of peroxisome proliferator-activated receptor (PPAR)-alpha and PPAR-gamma agonists on glucose and lipid metabolism in patients with type 2 diabetes mellitus.
Academic Article	Effects of pioglitazone on intramyocellular fat metabolism in patients with type 2 diabetes mellitus.
Academic Article	Effects of combined exenatide and pioglitazone therapy on hepatic fat content in type 2 diabetes.
Academic Article	Exenatide decreases hepatic fibroblast growth factor 21 resistance in non-alcoholic fatty liver disease in a mouse model of obesity and in a randomised controlled trial.
Concept	Hypoglycemic Agents
Academic Article	Potential of incretin-based therapies for non-alcoholic fatty liver disease.
Academic Article	Linagliptin improved glycaemic control without weight gain or hypoglycaemia in patients with type 2 diabetes inadequately controlled by a combination of metformin and pioglitazone: a 24-week randomized, double-blind study.
Academic Article	Ubc9 Impairs Activation of the Brown Fat Energy Metabolism Program in Human White Adipocytes.
Academic Article	Aleglitazar, a dual peroxisome proliferator-activated receptor-a and -? agonist, protects cardiomyocytes against the adverse effects of hyperglycaemia.
Academic Article	SGLT-2 Inhibition with Dapagliflozin Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Cardiomyopathy in Mice with Type 2 Diabetes. Further Augmentation of the Effects with Saxagliptin, a DPP4 Inhibitor.
Academic Article	GLP-1 Receptor Agonists and Cardiovascular Disease: a Meta-Analysis of Recent Cardiac Outcome Trials.
Academic Article	miR-30a targets gene networks that promote browning of human and mouse adipocytes.

Search Criteria

Hypoglycemic Agents